| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,173 |
15,945 |
$1.18M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,114 |
16,987 |
$994K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,269 |
4,683 |
$315K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,737 |
4,193 |
$277K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,134 |
1,876 |
$127K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,269 |
2,127 |
$86K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,215 |
7,585 |
$85K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,786 |
1,614 |
$73K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,650 |
4,969 |
$61K |
| 90670 |
|
2,694 |
2,424 |
$60K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,335 |
2,302 |
$47K |
| 90461 |
|
4,567 |
4,201 |
$43K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,139 |
2,617 |
$28K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
972 |
898 |
$23K |
| 90686 |
|
2,570 |
2,272 |
$23K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
339 |
290 |
$22K |
| 99173 |
|
5,554 |
4,882 |
$20K |
| 90680 |
|
1,605 |
1,491 |
$19K |
| 87634 |
|
326 |
299 |
$14K |
| 92551 |
|
2,920 |
2,584 |
$12K |
| 90723 |
|
1,142 |
1,025 |
$9K |
| 90677 |
|
755 |
716 |
$9K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
155 |
147 |
$7K |
| 90633 |
|
849 |
740 |
$6K |
| 90648 |
|
840 |
760 |
$6K |
| 90651 |
|
55 |
51 |
$6K |
| 87807 |
|
649 |
548 |
$6K |
| 90697 |
|
743 |
709 |
$5K |
| 99381 |
|
108 |
97 |
$5K |
| 96127 |
|
1,238 |
1,072 |
$5K |
| 36416 |
|
1,770 |
1,460 |
$4K |
| 90647 |
|
489 |
456 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
43 |
21 |
$3K |
| 99460 |
|
76 |
63 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
64 |
52 |
$3K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
29 |
25 |
$2K |
| 90656 |
|
287 |
286 |
$2K |
| 90734 |
|
26 |
25 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
330 |
315 |
$2K |
| 96112 |
|
27 |
25 |
$1K |
| 96161 |
|
450 |
354 |
$1K |
| 90674 |
|
141 |
123 |
$991.16 |
| 90710 |
|
139 |
121 |
$928.00 |
| 81003 |
|
307 |
271 |
$668.00 |
| 90698 |
|
76 |
70 |
$536.00 |
| 90707 |
|
85 |
71 |
$520.00 |
| 69210 |
|
19 |
13 |
$485.00 |
| 87081 |
|
57 |
50 |
$424.67 |
| 90716 |
|
67 |
58 |
$424.00 |
| 90671 |
|
66 |
66 |
$416.00 |
| 96113 |
|
13 |
13 |
$374.00 |
| 90700 |
|
45 |
41 |
$328.00 |
| 90696 |
|
46 |
40 |
$312.00 |
| 90685 |
|
36 |
26 |
$299.40 |
| 85018 |
|
285 |
249 |
$274.52 |
| 90744 |
|
34 |
32 |
$240.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
27 |
26 |
$11.80 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
140 |
127 |
$0.00 |
| 94760 |
|
102 |
96 |
$0.00 |